ACKNOWLEDGMENT OF REVIEWERS

Acknowledgment of Reviewers, 2006

JCO Mar 1 2007: 741–749. [Full Text] [PDF]

EDITORIALS

Translational Oncology: Transforming Cancer Care

Mary L. Disis

JCO Mar 1 2007: 750. [Full Text] [PDF]

Mind Your Elders: Therapeutic Implications of Epidermal Growth Factor Receptor Inhibition in Older Patients With Advanced Non–Small-Cell Lung Cancer

Corey J. Langer

JCO Mar 1 2007: 751–753. First published on Jan 16 2007; 10.1200/JCO.2006.08.9995. [Full Text] [PDF]

Clinical Uses of Microsatellite Instability Testing in Colorectal Cancer: An Ongoing Challenge

C. Richard Boland

JCO Mar 1 2007: 754–756. First published on Jan 16 2007; 10.1200/JCO.2006.09.4607. [Full Text] [PDF]

Role of Radiation Therapy in Localized Aggressive Lymphoma

Andrea K. Ng and Peter M. Mauch

JCO Mar 1 2007: 757–759. First published on Jan 16 2007; 10.1200/JCO.2006.09.5562. [Full Text] [PDF]

ORIGINAL REPORTS
Lung Cancer
	Phase II Clinical Trial of Chemotherapy-Naïve Patients 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer
	David M. Jackman, Beow Y. Yeap, Neal I. Lindeman, Panos Fidias, Michael S. Rabin, Jennifer Temel, Arthur T. Skarin, Matthew Meyerson, Alison J. Holmes, Ana M. Borras, Boris Freidlin, Patricia A. Ostler, Joan Lucca, Thomas J. Lynch, Bruce E. Johnson, and Pasi A. Jänne
	JCO Mar 1 2007: 760–766. First published on Jan 16 2007; 10.1200/JCO.2006.07.5754. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Prognostic and Predictive Roles of High-Degree Microsatellite Instability in Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study
	George P. Kim, Linda H. Colangelo, H. Samuel Wieand, Soonmyung Paik, Ilan R. Kirsch, Norman Wolmark, and Carmen J. Allegra
	JCO Mar 1 2007: 767–772. First published on Jan 16 2007; 10.1200/JCO.2006.05.8172. [Abstract] [Full Text] [PDF] [Hungarian PDF]
	Gene Expression Signature in Advanced Colorectal Cancer Patients Select Drugs and Response for the Use of Leucovorin, Fluorouracil, and Irinotecan
	Maguy Del Rio, Franck Molina, Caroline Bascoul-Mollevi, Virginie Copois, Frédéric Bibeau, Patrick Chalbos, Corinne Bareil, Andrew Kramar, Nicolas Salvetat, Caroline Fraslon, Emmanuel Conseiller, Virginie Granci, Benjamin Leblanc, Bernard Pau, Pierre Martineau, and Marc Ychou
	JCO Mar 1 2007: 773–780. [Abstract] [Full Text] [PDF] [Chinese PDF]

Genetic Testing for Cancer
	Clinicopathologic and Pedigree Differences in Amsterdam I–Positive Hereditary Nonpolyposis Colorectal Cancer Families According to Tumor Microsatellite Instability Status
	Laura Valle, Jose Perea, Pablo Carbonell, Victoria Fernandez, Ana M. Dotor, Javier Benitez, and Miguel Urioste
	JCO Mar 1 2007: 781–786. First published on Jan 16 2007; 10.1200/JCO.2006.06.9781. [Abstract] [Full Text] [PDF] [Chinese PDF]

Hematologic Malignancies
	CHOP Alone Compared With CHOP Plus Radiotherapy for Localized Aggressive Lymphoma in Elderly Patients: A Study by the Groupe d’Etude des Lymphomes de l’Adulte
	Christophe Bonnet, Georges Fillet, Nicolas Mounier, Gérard Ganem, Thierry Jo Molina, Catherine Thiéblemont, Christophe Fermé, Bruno Quesnel, Claude Martin, Christian Gisselbrecht, Hervé Tilly, and Félix Reyes
	JCO Mar 1 2007: 787–792. First published on Jan 16 2007; 10.1200/JCO.2006.07.0722. [Abstract] [Full Text] [PDF] [Polish PDF]
	Phase III Trial of Fludarabine Plus Cyclophosphamide Compared With Fludarabine for Patients With Previously Untreated Chronic Lymphocytic Leukemia: US Intergroup Trial E2997
	Ian W. Flinn, Donna S. Neuberg, Michael R. Grever, Gordon W. Dewald, John M. Bennett, Elisabeth M. Paietta, Mohamad A. Hussein, Frederick R. Appelbaum, Richard A. Larson, Dennis F. Moore, Jr, and Martin S. Tallman
	JCO Mar 1 2007: 793–798. First published on Feb 5 2007; 10.1200/JCO.2006.08.0762. [Abstract] [Full Text] [PDF]
	Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997
	Michael R. Grever, David M. Lucas, Gordon W. Dewald, Donna S. Neuberg, John C. Reed, Shinichi Kitada, Ian W. Flinn, Martin S. Tallman, Frederick R. Appelbaum, Richard A. Larson, Elisabeth Paietta, Diane F. Jelinek, John G. Gribben, and John C. Byrd
	JCO Mar 1 2007: 799–804. First published on Feb 5 2007; 10.1200/JCO.2006.08.3089. [Abstract] [Full Text] [PDF]
	Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium
	Daphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai, Philippe Gaulard, Wolfram Klapper, Abigail Lee, Birgitta Sander, Christoph Thorns, Elias Campo, Thierry Molina, Andrew Norton, Anton Hagenbeek, Sandra Horning, Andrew Lister, John Raemaekers, Randy D. Gascoyne, Gilles Salles, and Edie Weller
	JCO Mar 1 2007: 805–812. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Favorable Outcome for Adolescents With Acute Lymphoblastic Leukemia Treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols
	Elly Barry, Daniel J. DeAngelo, Donna Neuberg, Kristen Stevenson, Mignon L. Loh, Barbara L. Asselin, Ronald D. Barr, Luis A. Clavell, Craig A. Hurwitz, Albert Moghrabi, Yvan Samson, Marshall Schorin, Harvey J. Cohen, Stephen E. Sallan, and Lewis B. Silverman
	JCO Mar 1 2007: 813–819. [Abstract] [Full Text] [PDF]

Breast Cancer
	Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group
	Michael F.X. Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, Stephan Grampp, Helmut Kaessmann, Marianne Schmid, Christian Menzel, Jutta Claudia Piswanger-Soelkner, Arik Galid, Martina Mittlboeck, Hubert Hausmaninger, and Raimund Jakesz
	JCO Mar 1 2007: 820–828. First published on Dec 11 2006; 10.1200/JCO.2005.02.7102. [Abstract] [Full Text] [PDF] [Hungarian PDF] [Publisher's Note]
	Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer
	Adam Brufsky, W. Graydon Harker, J. Thaddeus Beck, Robert Carroll, Elizabeth Tan-Chiu, Christopher Seidler, John Hohneker, Leo Lacerna, Stephanie Petrone, and Edith A. Perez
	JCO Mar 1 2007: 829–836. First published on Dec 11 2006; 10.1200/JCO.2005.05.3744. [Abstract] [Full Text] [PDF]

Neurooncology
	Direct Intracerebral Delivery of Cintredekin Besudotox (IL13-PE38QQR) in Recurrent Malignant Glioma: A Report by the Cintredekin Besudotox Intraparenchymal Study Group
	Sandeep Kunwar, Michael D. Prados, Susan M. Chang, Mitchel S. Berger, Frederick F. Lang, Joseph M. Piepmeier, John H. Sampson, Zvi Ram, Philip H. Gutin, Robert D. Gibbons, Kenneth D. Aldape, David J. Croteau, Jeffrey W. Sherman, and Raj K. Puri
	JCO Mar 1 2007: 837–844. [Abstract] [Full Text] [PDF]

Genitourinary Cancer
	Interleukin-4 Promoter Polymorphisms: A Genetic Prognostic Factor for Survival in Metastatic Renal Cell Carcinoma
	Thomas Kleinrath, Christoph Gassner, Peter Lackner, Martin Thurnher, and Reinhold Ramoner
	JCO Mar 1 2007: 845–851. [Abstract] [Full Text] [PDF]

Gynecologic Cancer
	Tumor Vascular Proteins As Biomarkers in Ovarian Cancer
	Ronald J. Buckanovich, Dimitra Sasaroli, Anne O'Brien-Jenkins, Jeffrey Botbyl, Rachel Hammond, Dionysios Katsaros, Raphael Sandaltzopoulos, Lance A. Liotta, Phyllis A. Gimotty, and George Coukos
	JCO Mar 1 2007: 852–861. [Abstract] [Full Text] [PDF]

Head and Neck Cancer
	Low Levels of Circulating Invariant Natural Killer T Cells Predict Poor Clinical Outcome in Patients With Head and Neck Squamous Cell Carcinoma
	Johan W. Molling, Jacqueline A.E. Langius, Johannes A. Langendijk, C. René Leemans, Hetty J. Bontkes, Hans J.J. van der Vliet, B. Mary E. von Blomberg, Rik J. Scheper, and Alfons J.M. van den Eertwegh
	JCO Mar 1 2007: 862–868. [Abstract] [Full Text] [PDF]

Melanoma
	Tumor-Infiltrating Lymphocytes Predict Sentinel Lymph Node Positivity in Patients With Cutaneous Melanoma
	Rebecca C. Taylor, Ami Patel, Katherine S. Panageas, Klaus J. Busam, and Mary S. Brady
	JCO Mar 1 2007: 869–875. [Abstract] [Full Text] [PDF]

Phase I and Clinical Pharmacology
	Clinical Activity and Immune Modulation in Cancer Patients Treated With CP-870,893, a Novel CD40 Agonist Monoclonal Antibody
	Robert H. Vonderheide, Keith T. Flaherty, Magi Khalil, Molly S. Stumacher, David L. Bajor, Natalie A. Hutnick, Patricia Sullivan, J. Joseph Mahany, Maryann Gallagher, Amy Kramer, Stephanie J. Green, Peter J. O'Dwyer, Kelli L. Running, Richard D. Huhn, and Scott J. Antonia
	JCO Mar 1 2007: 876–883. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Sunitinib: From Rational Design to Clinical Efficacy
	Laura Q.M. Chow and S. Gail Eckhardt
	JCO Mar 1 2007: 884–896. [Abstract] [Full Text] [PDF] [Polish PDF] [Russian PDF]

DIAGNOSIS IN ONCOLOGY

Hepatic Pneumatosis As a Complication of an Abdominal Desmoid Tumor

Aleix Prat, Sergio Peralta, Hug Cuéllar, and Alberto Ocaña

JCO Mar 1 2007: 897–898. [Full Text] [PDF]

Bleomycin-Induced Flagellate Erythema

Yi-Bin Chen, Aliyah Rahemtullah, Eric Breeden, and Ephraim P. Hochberg

JCO Mar 1 2007: 898–900. [Full Text] [PDF]

Complete Response From Thalidomide in Angiosarcoma After Treatment of Breast Cancer

Vinod Raina, Manju Sengar, Nootan K. Shukla, Sankaranavamsam S. Deo, Bidhu K. Mohanty, Dayanand Sharma, Ruma Ray, Prasenjit Das, and Goura K. Rath

JCO Mar 1 2007: 900–901. [Full Text] [PDF]

ART OF ONCOLOGY

Conflicts of Interest and the Physician-Patient Relationship in the Era of Direct-to-Patient Advertising

Reshma Jagsi

JCO Mar 1 2007: 902–905. [Full Text] [PDF]

CORRESPONDENCE
	New Proposal for Postsurgery Pathologic Staging of Esophageal or Gastroesophageal Junction Adenocarcinoma: Why Bother?
	Jaffer A. Ajani
	JCO Mar 1 2007: 906–907. [Full Text] [PDF]
	It Is Time for a Proper Staging System for Adenocarcinoma of the Gastroesophageal Junction
	Corrado Pedrazzani, Giovanni de Manzoni, Daniele Marrelli, and Franco Roviello
	JCO Mar 1 2007: 907–908. [Full Text] [PDF]
	In Reply
	Sjoerd M. Lagarde, Fiebo J.W. ten Kate, Johannes B. Reitsma, Olivier R.C. Busch, and J. Jan B. van Lanschot
	JCO Mar 1 2007: 908–909. [Full Text] [PDF]
	Outcome Prediction to Erlotinib in Gastroesophageal Adenocarcinomas: Can We Improve Epidermal Growth Factor Receptor and Phospho-AKT Testing?
	Nicola Personeni
	JCO Mar 1 2007: 910. [Full Text] [PDF]
	In Reply
	Tomislav Dragovich and Cecilia Fenoglio-Preiser
	JCO Mar 1 2007: 911. [Full Text] [PDF]
	Genetic Counseling About Reproductive Options for Hereditary Cancer: What Is the Standard of Care?
	Beth N. Peshkin, Rachel H. Nusbaum, and Tiffani A. DeMarco
	JCO Mar 1 2007: 911–912. [Full Text] [PDF]
	In Reply
	Kenneth Offit, Kelly Kohut, Donna Bernstein, Shelly Cummings, Melody White, Michal Sagi, and Jessica G. Davis
	JCO Mar 1 2007: 913. [Full Text] [PDF]
	Microsatellite Instability Testing in Genetically Heterogeneous Populations
	Silvia L. Cossio, Patricia Ashton-Prolla, Maria-Cátira Bortolini, Renata S. Coura, Roberto Giugliani, and João C. Prolla
	JCO Mar 1 2007: 913–914. [Full Text] [PDF]
	In Reply
	Olivier Buhard, Jean-François Fléjou, Alex Duval, and Richard Hamelin
	JCO Mar 1 2007: 914–915. [Full Text] [PDF]
	It Is Follicular... . So, Why CHOP?
	Chadi Nabhan
	JCO Mar 1 2007: 915–916. [Full Text] [PDF]
	In Reply
	Oliver W. Press and Richard I. Fisher
	JCO Mar 1 2007: 916–917. [Full Text] [PDF]
	More Thoughts on the Reporting of Adverse Events in Cancer Clinical Trials
	Martine Extermann
	JCO Mar 1 2007: 918. [Full Text] [PDF]
	In Reply
	Orit Scharf and A. Dimitrios Colevas
	JCO Mar 1 2007: 918–919. [Full Text] [PDF]
	Epoeitin Alfa Use in Children Undergoing Myelosuppressive Chemotherapy
	Ian M. Waxman
	JCO Mar 1 2007: 919. [Full Text] [PDF]
	In Reply
	Bassem I. Razzouk and Jeffrey D. Hord
	JCO Mar 1 2007: 919–920. [Full Text] [PDF]
	Imatinib in Melanoma: A Selective Treatment Option Based on KIT Mutation Status?
	Jürgen C. Becker, Eva B. Bröcker, Dirk Schadendorf, and Selma Ugurel
	JCO Mar 1 2007: e9. [Full Text] [PDF]
	Need for a New Trial to Evaluate Adjuvant Postoperative Radiotherapy in Non–Small-Cell Lung Cancer Patients With N2 Mediastinal Involvement
	Cecile Le Péchoux, Ariane Dunant, Jean-Pierre Pignon, Dirk De Ruysscher, Françoise Mornex, Suresh Senan, Francesc Casas, Allan Price, and Bernard Milleron
	JCO Mar 1 2007: e10–e11. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.